Axsome Therapeutics, Inc.
Ticker: 1579428
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 191.20+11.8% | 170.99+14.0% | 150.04+23.5% | 121.46+15.9% | 104.76+20.2% | 87.17+16.2% | 75.00+29.8% | 57.79 |
| Total Income | 191.20+11.8% | 170.99+14.0% | 150.04+23.5% | 121.46+15.9% | 104.76+20.2% | 87.17+16.2% | 75.00+29.8% | 57.79 |
| EXPENSES | ||||||||
| Expenditure | 254.56+17.3% | 217.10+16.2% | 186.76+4.7% | 178.45+6.6% | 167.39+1.3% | 165.21+16.1% | 142.27+18.6% | 119.91 |
| Tax | 0.00 | 0.00+100.0% | -0.96 | 0.00 | 0.00 | 0.00 | 0.00+100.0% | -0.68 |
| PROFIT | ||||||||
| PBT | -64.54-36.7% | -47.23+3.5% | -48.93+17.6% | -59.41+8.0% | -64.60+18.6% | -79.35-16.1% | -68.36-8.7% | -62.88 |
| Net Profit | -64.54-36.7% | -47.23+1.5% | -47.97+19.3% | -59.41+8.0% | -64.60+18.6% | -79.35-16.1% | -68.36-9.9% | -62.20 |
| KEY METRICS | ||||||||
| OPM % | -33.14%-6.17pp | -26.97%-2.50pp | -24.47%+22.44pp | -46.91%+12.86pp | -59.78%+29.76pp | -89.54%+0.16pp | -89.70%+10.30pp | -100.00% |
| NPM % | -33.76%-6.14pp | -27.62%+4.35pp | -31.97%+16.94pp | -48.91%+12.75pp | -61.66%+29.36pp | -91.03%+0.12pp | -91.14%+8.85pp | -100.00% |
| EPS | -1.26-34.0% | -0.94+3.1% | -0.97+20.5% | -1.22+9.0% | -1.34+19.8% | -1.67-16.0% | -1.44-9.1% | -1.32 |
Corporate Events
Board MeetingAXSM
20265Jun
Board Meeting
Adoption of Executive Severance and Change in Control Plan f…
SEC Filing ↗ Board MeetingAXSM
20265Jun
Board Meeting
Annual Meeting of Stockholders to vote on the election of tw…
SEC Filing ↗